Russell Cerejo, MD
Neurology · Pittsburgh, PANPI 1265750715
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Microvention, Inc. at 29.6% of the total. Reporting peaked in 2019 at $1,858 and has fallen 79.9% since, to $373 in 2025.
Across 38 payments — averaging $139.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microvention, Inc.$2K
- Genentech, Inc.$2K
- Ischemaview, Inc.$525
- Medtronic$371
- Penumbra, Inc.$338
- Stryker$249
- plus $737 from 9 others
Across 15 payments — averaging $5890.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$68K
- Medical Device Business Services, Inc.$20K
What the payments were for
- Consulting fees$2,04038%
- Travel & lodging$1,09621%
- Food & beverage$2,14941%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microvention, Inc. | 11 | $1,571 |
| Genentech, Inc. | 1 | $1,515 |
| Ischemaview, Inc. | 1 | $525 |
| Medtronic | 6 | $371 |
| Penumbra, Inc. | 3 | $338 |
| Stryker | 2 | $249 |
| Johnson & Johnson(2 entities) | 3 | $191 |
| Terumo Medical Corporation | 1 | $149 |
| Viz.ai, Inc. | 1 | $139 |
| Biogen | 1 | $83 |
| Genentech USA, Inc. | 4 | $74 |
| Aesculap, Inc. | 1 | $38 |
| Route 92 Medical, Inc. | 1 | $24 |
| CSL Behring | 1 | $20 |
| Imperative Care, Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TNKase$1,515
- WEB$1,362
- UNIVERSAL NEURO 3$169
- CEREPAK UNIFORM$159
- HydroPearl$149
- AZUR$149
- Navicross$149
- Glidesheath$149
- Viz.AI LVO$139
- Penumbra System$136
- AXIUM PRIMETM$126
- REAL System$118
- Pipeline$100
How this compares
$5,306 in reported general payments places this provider in the 70th percentile of 941 neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 18 | $14,563 |
| Levetiracetam | 17 | $1,099 |
| Atorvastatin Calcium | 33 | $577 |
| ClopidogrelClopidogrel Bisulfate | 38 | $481 |
| Warfarin Sodium | 13 | $98 |
| Rosuvastatin Calcium | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other neurology in Pittsburgh
- Anoopum GuptaPittsburgh$592K
- Thomas ScottPittsburgh$476K
- James ValerianoPittsburgh$416K
- Amber van LaarPittsburgh$413K
- Andrea SynowiecPittsburgh$386K
- Dolores Dominguez SantamariaPittsburgh$265K
- Heather MouryPittsburgh$186K
- Troy DesaiPittsburgh$174K
- Richard KasdanPittsburgh$172K
- David LobasPittsburgh$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.